Skip to Content

Eventide Healthcare & Life Sciences I ETIHX

Analyst rating as of
NAV / 1-Day Return
43.09  /  4.33 %
Total Assets
2.0 Bil
Adj. Expense Ratio
1.290%
Expense Ratio
1.290%
Fee Level
High
Longest Manager Tenure
8.94 years
Category
Health
Investment Style
Small Growth
Min. Initial Investment
100,000
Status
Open
TTM Yield
0.00%
Turnover
62%
Premium

Morningstar’s Analysis

Will ETIHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

This fund's strong track record comes with plenty of risks.

Senior Analyst

Summary

| |

Eventide Healthcare & Life Sciences has taken investors on a roller-coaster ride recently, illustrating both the risks and the possible rewards that come with owning it. The relatively cheap I shares earn a Morningstar Analyst Rating of Bronze, while the more expensive share classes are rated Neutral.

Unlock our full analysis with Morningstar Premium